跳至主要内容
临床试验/NCT02443714
NCT02443714已完成4 期

Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro Using Needle-Free Jet Injection Technology

Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Early insulin exposure

研究概览

简要总结

Needle-free jet injector provides an alternative for patients with diabetes treated by insulin. This study aimed at evaluating pharmacokinetics and pharmacodynamics (PK-PD) profiles of lispro administered by jet injector and conventional pen.

详细描述

This is a randomized, double-blind, double-dummy, crossover study. Eighteen healthy volunteers will be recruited. Lispro (0.2 units/kg) will be administered by jet injector or by conventional pen and a seven-hour euglycemic clamp test will be performed. PK-PD profiles of lispro will be calculated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • The range of height should be 170±10cm.
  • The range of weight should be ±10%kg.
  • Liver and renal function should be normal.
  • Health subjects with no chronic diseases or medications.

排除标准

  • Drug allergy, history of allergic disorders or allergies.
  • A history of liver or kidney disease.
  • Smoker, drinkers.
  • Subjects who participated in other drug trials within a month.
  • Subjects who used medication which is known to organ damage.

结局指标

主要结局

Early insulin exposure

时间窗: The area under the curve (AUC) of insulin from 0 to 30min (AUCins, 0-30min)

次要结局

  • Pharmacokinetics(50% insulin absorption time (Ins-TAUC50%))
  • Pharmacodynamics(Maximum GIR (GIRmax))

研究者

发起方
Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qifu Li

Professor

Chongqing Medical University

研究点 (1)

Loading locations...

相似试验